Toronto Dominion Bank Cardiol Therapeutics Inc. Transaction History

Toronto Dominion Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.67 - $2.97 $1,169 - $2,079	700 Added 679.61%	803 $1,000
Q1 2024 May 14, 2024	SELL	$0.88 - $2.06 $114 - $267	-130 Reduced 55.79%	103 $0
Q4 2023 Feb 13, 2024	BUY	$0.67 - $1.0 $138 - $207	207 Added 796.15%	233 $0
Q3 2023 Feb 14, 2024	SELL	$0.76 - $1.19 $157 - $246	-207 Reduced 88.84%	26 $0
Q3 2023 Nov 14, 2023	BUY	$0.76 - $1.19 $19 - $30	26 New	26 $0
Q1 2023 May 11, 2023	BUY	$0.47 - $0.81 $270 - $465	575 New	575 $0
Q1 2022 May 09, 2022	SELL	$1.25 - $2.31 $327 - $605	-262 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$1.83 - $4.86 $1,134 - $3,013	-620 Reduced 70.29%	262 $0
Q3 2021 Nov 08, 2021	BUY	$2.03 - $4.8 $1,790 - $4,233	882 New	882 $4,000

5.07M

5.2K

9.5K

Ticker CRDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 61,942,500
Market Cap $94.8M
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.